基本信息
浏览量:413
职业迁徙
个人简介
Christophe Massard (MD, PhD) medical oncologist, is Chair of Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. He is Consultant Medical Oncologist and full time cancer specialist at Gustave Roussy, half time at Drug Development department (DDD) and joined the faculty in 2006. He is primarily involved in translational cancer research and the design and conduct of early-phase biomarker-driven clinical trials, with a
special interest in Genito urinary cancer and Central Nervous System tumor.Dr Massard is member of ESMO, ASCO, AACR. Over the last 5 years, he was the principal investigators of 15 phase I trials, 1 phase II trial (prostate cancer), and subinvestigator of more than 80 clinical trials (phase 1 trials and GU cancers). He is also involved in translational research aspects related to precision medicine(MOSCATO, MATCHR and PETRUS program). Dr Massard has contributed to over 180 peer-reviewed publications, including publications in European Urology, Annals of Oncology and Journal of Clinical Oncology. . He is also a member of the editorial boards of Bulletin du Cancer, Investigational New Drugs, and European Journal of Cancer.
special interest in Genito urinary cancer and Central Nervous System tumor.Dr Massard is member of ESMO, ASCO, AACR. Over the last 5 years, he was the principal investigators of 15 phase I trials, 1 phase II trial (prostate cancer), and subinvestigator of more than 80 clinical trials (phase 1 trials and GU cancers). He is also involved in translational research aspects related to precision medicine(MOSCATO, MATCHR and PETRUS program). Dr Massard has contributed to over 180 peer-reviewed publications, including publications in European Urology, Annals of Oncology and Journal of Clinical Oncology. . He is also a member of the editorial boards of Bulletin du Cancer, Investigational New Drugs, and European Journal of Cancer.
研究兴趣
论文共 949 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Antonin Levy,Daphné Morel,Matthieu Texier,Roger Sun,Jerome Durand-Labrunie, Maria E Rodriguez-Ruiz, Severine Racadot, Stéphane Supiot,Nicolas Magné, Stacy Cyrille,Guillaume Louvel,Christophe Massard,
CLINICAL PHARMACOLOGY & THERAPEUTICS (2024)
European Journal of Cancer (2024): 114075-114075
Matthieu Delaye,Littisha Lawrance,Younes Belkouchi, Felix Wirth,Pierre Decazes,Alexandre Bône,Kaïssa Ouali,Antoine Hollebecque,Cristina Smolenschi,Rastislav Bahleda,Anas Gazzah,Stéphane Champiat,
Layal Rached,Arthur Geraud, Maxime Frelaut, Zoe A. P. Thomas,Vincent Goldschmidt, Geoffroy Beraud-Chaulet, Celine Nagera-Lazarovici,Francois -Xavier Danlos,Clemence Henon,Claudia Parisi,Anas Gazzah,Rastilav Bahleda,
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024): 104212-104212
Octave Letissier, Cristina Smolenschi, Antoine Hollebecque, Damien Vasseur, Stephane Champiat, Rastilav Bahleda, Anas Gazzah, Jean-Marie Michot,Francois-Xavier Danlos, Kaissa Ouali, Clemence Henon, Claudia Parisi,
Laila Belcaid,Sophie Cousin,Arnaud Bayle,Melissa Alame,Etienne Rouleau, Laura Blouin,Ludovic Lacroix,Damien Vasseur,Maxime Brunet, Sofiane Taleb,Isabelle Soubeyran,Veronique Debien,
Cancer Researchno. 7_Supplement (2024)
Cancer Researchno. 6_Supplement (2024): 5068-5068
Cancer Researchno. 6_Supplement (2024): 6406-6406
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn